BackGuizhou Yibai Pharmaceutical , Ltd. Overview

Guizhou Yibai Pharmaceutical , Ltd. Inventory

Guizhou Yibai Pharmaceutical , Ltd.'s inventory is $530M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$526.34M
↓ 7.90% YoYΔ $-45.17M vs prior year quarter

Peer trimmed avg / median

Loading

Guizhou Yibai Pharmaceutical , Ltd. Inventory History

Loading

Guizhou Yibai Pharmaceutical , Ltd. vs. peers: Inventory Comparison

Loading

Guizhou Yibai Pharmaceutical , Ltd. Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Guizhou Yibai Pharmaceutical , Ltd. (600594.SS) FAQ

As of the most recent data (June 2026), 600594.SS shows a inventory of $530M. That compares with $570M in the prior-year period — down 7.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600594.SS's inventory is now $530M (was $570M) — a 7.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Guizhou Yibai Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 600594.SS's inventory over time shows whether Guizhou Yibai Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $530M That compares with $570M in the prior-year period — down 7.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Guizhou Yibai Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $530M) with ownership activity and broader fundamentals.